Design Therapeutics (NASDAQ:DSGN) outlined its near-term clinical priorities and key upcoming data readouts during a ...

The landscape of dementia diagnostics is undergoing a paradigm shift with the emergence of liquid biopsy, blood-based biomarkers (BBMs), and blood-derived ...

TEM advances precision oncology as studies validate IPS, PurIST and xF+ diagnostics, highlighting stronger guidance for cancer therapy and biomarker detection.

Autoimmune and autoinflammatory diseases are distinct but related categories of disorders characterized by an abnormal immune response. While autoimmune diseases involve adaptive immunity and the ...

Detailed price information for Alx Oncology Holdings Inc (ALXO-Q) from The Globe and Mail including charting and trades.

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

Autism diagnostic specialist BlinkLab (ASX: BB1) has entered into a new partnership with the US-based SHANK2 foundation. Listen to the HotCopper podcast for in-depth discussions and insights on all ...

With the support of the WHOOP Medical Advisory Board, including Dr. Robin Berzin and Dr. Hazel Wallace, and in tandem with their recent collaboration with Clue, a leader in menstrual and reproductive ...

Explore the latest developments showcased at World ADC, highlighting smarter payloads and precise targeting in drug discovery.

In an interview, Vincent Ma, MD, explores the clinical utility of circulating tumor DNA dynamics to assess early outcomes in ...

The world’s largest professional psychiatry organization is preparing for the day when biological indicators help diagnose and treat mental illness.